within Pharmacolibrary.Drugs.ATC.J;

model J01XX09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.011 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 280 / 1000000,
    adminCount     = 1,
    Vd             = 0.0001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Daptomycin is a cyclic lipopeptide antibiotic used for the treatment of infections caused by Gram-positive bacteria, including complicated skin and skin structure infections and Staphylococcus aureus bacteremia, including right-sided infective endocarditis. It is approved by the FDA and continues to be in clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for healthy adult volunteers after a single intravenous 4 mg/kg dose.</p><h4>References</h4><ol><li><p>Wu, J, et al., &amp; Wu, D (2024). Population pharmacokinetics of intravenous daptomycin in critically ill patients: implications for selection of dosage regimens. <i>Frontiers in pharmacology</i> 15 1378872–None. DOI:<a href=&quot;https://doi.org/10.3389/fphar.2024.1378872&quot;>10.3389/fphar.2024.1378872</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38756382/&quot;>https://pubmed.ncbi.nlm.nih.gov/38756382</a></p></li><li><p>Ishii, M, et al., &amp; Yoshitsugu, H (2023). Pharmacokinetics of intravenous daptomycin in Japanese pediatric patients: Pharmacokinetic comparisons supporting dosing recommendations in Japanese pediatric patients. <i>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</i> 29(6) 592–598. DOI:<a href=&quot;https://doi.org/10.1016/j.jiac.2023.02.012&quot;>10.1016/j.jiac.2023.02.012</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36868408/&quot;>https://pubmed.ncbi.nlm.nih.gov/36868408</a></p></li><li><p>Sullins, AK, &amp; Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. <i>Paediatric drugs</i> 15(2) 93–117. DOI:<a href=&quot;https://doi.org/10.1007/s40272-013-0017-5&quot;>10.1007/s40272-013-0017-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23529866/&quot;>https://pubmed.ncbi.nlm.nih.gov/23529866</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01XX09;
